Vanda Pharmaceuticals (VNDA) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -426.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -426.16% |
| Dec 31, 2025 | 632.76% |
| Sep 30, 2025 | -327.14% |
| Jun 30, 2025 | -39.46% |
| Mar 31, 2025 | 188.56% |
| Dec 31, 2024 | 104.25% |
| Sep 30, 2024 | -107.58% |
| Jun 30, 2024 | 89.13% |
| Mar 31, 2024 | -104.86% |
| Dec 31, 2023 | -155.61% |
| Sep 30, 2023 | 472.39% |
| Jun 30, 2023 | -2,224.23% |
| Mar 31, 2023 | 1,369.27% |
| Dec 31, 2022 | 5,078.73% |
| Sep 30, 2022 | -31.03% |
| Jun 30, 2022 | 40.96% |
| Mar 31, 2022 | 34.19% |
| Dec 31, 2021 | -59.24% |
| Sep 30, 2021 | 82.22% |
| Jun 30, 2021 | -149.03% |
| Mar 31, 2021 | -44.08% |
| Dec 31, 2020 | -28.69% |
| Sep 30, 2020 | -424.02% |
| Jun 30, 2020 | 149.24% |
| Mar 31, 2020 | 174.63% |
| Dec 31, 2019 | 2,161.75% |
| Sep 30, 2019 | -7,291.92% |
| Jun 30, 2019 | 112.90% |
| Mar 31, 2019 | -121.88% |
| Dec 31, 2018 | -97.70% |
| Sep 30, 2018 | -101.19% |
| Jun 30, 2018 | -1,501.09% |
| Mar 31, 2018 | 698.96% |
| Dec 31, 2017 | 41.64% |
| Sep 30, 2017 | -12.86% |
| Jun 30, 2017 | 62.08% |
| Mar 31, 2017 | -67.86% |
| Dec 31, 2016 | 89.82% |
| Sep 30, 2016 | 717.09% |
| Jun 30, 2016 | -200.12% |
| Mar 31, 2016 | 56.92% |
| Dec 31, 2015 | -91.10% |
| Sep 30, 2015 | 8.01% |
| Jun 30, 2015 | 159.12% |
| Mar 31, 2015 | -30.64% |
| Dec 31, 2014 | 158.90% |
| Sep 30, 2014 | -104.37% |
| Jun 30, 2014 | -317.05% |
| Mar 31, 2014 | -201.63% |
| Dec 31, 2013 | -391.32% |
| Sep 30, 2013 | 280.56% |
| Jun 30, 2013 | 54.05% |
| Mar 31, 2013 | 4.90% |
| Dec 31, 2012 | -157.09% |
| Sep 30, 2012 | 1.93% |
| Jun 30, 2012 | -542.27% |
| Mar 31, 2012 | 102.50% |
| Dec 31, 2011 | 146.06% |
| Sep 30, 2011 | 123.01% |